FIELD: chemistry.
SUBSTANCE: invention relates to polypeptides that act as modulators of complement activity, pharmaceutical compositions containing said polypeptides, and methods of using such modulators as therapeutic agents.
EFFECT: treatment of complement-related diseases, for example, such as inflammatory disease, wound, injury.
18 cl, 7 dwg, 18 tbl, 22 ex
Title | Year | Author | Number |
---|---|---|---|
COMPLEMENT ACTIVITY MODULATION | 2015 |
|
RU2778514C2 |
INHIBITORS OF XA FACTOR | 1995 |
|
RU2152954C1 |
PEPTIDOMIMETIC MACROCYCLES | 2011 |
|
RU2582678C2 |
p53 PEPTIDOMIMETIC MACROCYCLES | 2013 |
|
RU2642299C2 |
METHOD (VERSIONS) AND PREPARATION FOR MODIFICATION OF EATING BEHAVIOUR | 2002 |
|
RU2519748C2 |
POTENT COMPSTATIN ANALOGS | 2012 |
|
RU2656102C2 |
NOVEL POLYPEPTIDES | 2014 |
|
RU2674604C2 |
CELL-REACTIVE COMPSTATIN ANALOGS, LONG-ACTING COMPSTATIN ANALOGS, OR TARGETED COMPSTATIN ANALOGS AND USES THEREOF | 2012 |
|
RU2653439C9 |
EFFICIENT COMPSTATIN ANALOGUES | 2006 |
|
RU2474586C2 |
COMPLEMENT ACTIVITY MODULATORS | 2017 |
|
RU2778811C2 |
Authors
Dates
2018-10-29—Published
2015-06-12—Filed